Journal article

Defining the substrate specificity determinants recognized by the active site of C-terminal Src kinase-homologous kinase (CHK) and identification of β-synuclein as a potential CHK physiological substrate

KK Ia, GR Jeschke, Y Deng, MA Kamaruddin, NA Williamson, DB Scanlon, JG Culvenor, MI Hossain, AW Purcell, S Liu, HJ Zhu, B Catimel, BE Turk, HC Cheng

Biochemistry | Published : 2011

Abstract

C-Terminal Src kinase-homologous kinase (CHK) exerts its tumor suppressor function by phosphorylating the C-terminal regulatory tyrosine of the Src-family kinases (SFKs). The phosphorylation suppresses their activity and oncogenic action. In addition to phosphorylating SFKs, CHK also performs non-SFK-related functions by phosphorylating other cellular protein substrates. To define these non-SFK-related functions of CHK, we used the "kinase substrate tracking and elucidation" method to search for its potential physiological substrates in rat brain cytosol. Our search revealed β-synuclein as a potential CHK substrate, and Y127 in β-synuclein as the preferential phosphorylation site. Using pept..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Institute of General Medical Sciences


Funding Acknowledgements

The work described here was supported by project grants from the NHMRC of Australia (566743 to H.-C.C. and J.G.C.), Cancer Council Victoria (to H.-C.C. and H.-J.Z.), and the National Institutes of Health (R01 GM079498 and R21 CA147993 to BET.). A.W.P. is supported by a Senior Research Fellowship from the NHMRC of Australia. K.K.I. was supported by scholarships from the Faculty of Medicine, Dentistry and Health Sciences of the University of Melbourne.